Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.

Sarma NJ, Tiriveedhi V, Crippin JS, Chapman WC, Mohanakumar T.

J Virol. 2014 Apr;88(7):3733-43. doi: 10.1128/JVI.03060-13. Epub 2014 Jan 15.

2.

Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression.

Tiriveedhi V, Upadhya GA, Busch RA, Gunter KL, Dines JN, Knolhoff BL, Jia J, Sarma NJ, Ramachandran S, Anderson CD, Mohanakumar T, Chapman WC.

Transpl Immunol. 2014 Mar;30(2-3):93-8. doi: 10.1016/j.trim.2013.12.003. Epub 2013 Dec 29.

PMID:
24380732
3.

Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis.

Ramachandran S, Ilias Basha H, Sarma NJ, Lin Y, Crippin JS, Chapman WC, Mohanakumar T.

PLoS One. 2013 Aug 12;8(8):e70744. doi: 10.1371/journal.pone.0070744. eCollection 2013.

4.

Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Angaswamy N, Tiriveedhi V, Sarma NJ, Subramanian V, Klein C, Wellen J, Shenoy S, Chapman WC, Mohanakumar T.

Hum Immunol. 2013 Nov;74(11):1478-85. doi: 10.1016/j.humimm.2013.07.002. Epub 2013 Jul 19. Review.

5.

Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.

Tiriveedhi V, Gautam B, Sarma NJ, Askar M, Budev M, Aloush A, Hachem R, Trulock E, Myers B, Patterson AG, Mohanakumar T.

J Heart Lung Transplant. 2013 Aug;32(8):807-14. doi: 10.1016/j.healun.2013.06.003.

6.

Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.

Sarma NJ, Yaseen NR.

PLoS One. 2013 Jun 26;8(6):e67032. doi: 10.1371/journal.pone.0067032. Print 2013.

7.
8.

Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens.

Tiriveedhi V, Takenaka M, Sarma NJ, Gelman AG, Mohanakumar T.

J Heart Lung Transplant. 2013 Jul;32(7):714-22. doi: 10.1016/j.healun.2013.04.006. Epub 2013 May 2.

9.

Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway.

Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T.

PLoS One. 2012;7(11):e50826. doi: 10.1371/journal.pone.0050826. Epub 2012 Nov 30.

10.

The new nucleoporin: regulator of transcriptional repression and beyond.

Sarma NJ, Willis K.

Nucleus. 2012 Nov-Dec;3(6):508-15. doi: 10.4161/nucl.22427. Epub 2012 Oct 9.

11.

Modulation of immune responses following solid organ transplantation by microRNA.

Sarma NJ, Tiriveedhi V, Ramachandran S, Crippin J, Chapman W, Mohanakumar T.

Exp Mol Pathol. 2012 Dec;93(3):378-85. doi: 10.1016/j.yexmp.2012.09.020. Epub 2012 Oct 1. Review.

12.

Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.

Sarma NJ, Tiriveedhi V, Angaswamy N, Mohanakumar T.

Hum Immunol. 2012 Dec;73(12):1275-81. doi: 10.1016/j.humimm.2012.06.014. Epub 2012 Jul 10. Review.

13.

The nuclear pore complex mediates binding of the Mig1 repressor to target promoters.

Sarma NJ, Buford TD, Haley T, Barbara-Haley K, Santangelo GM, Willis KA.

PLoS One. 2011;6(11):e27117. doi: 10.1371/journal.pone.0027117. Epub 2011 Nov 14.

14.

Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.

Tiriveedhi V, Sarma NJ, Subramanian V, Fleming TP, Gillanders WE, Mohanakumar T.

Hum Immunol. 2012 Jan;73(1):11-6. doi: 10.1016/j.humimm.2011.10.017. Epub 2011 Oct 23.

15.

Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.

Sarma NJ, Yaseen NR.

J Biol Chem. 2011 Nov 11;286(45):38989-9001. doi: 10.1074/jbc.M111.297952. Epub 2011 Sep 21.

16.

Colony forming cell (CFC) assay for human hematopoietic cells.

Sarma NJ, Takeda A, Yaseen NR.

J Vis Exp. 2010 Dec 18;(46). pii: 2195. doi: 10.3791/2195.

17.

Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.

Takeda A, Sarma NJ, Abdul-Nabi AM, Yaseen NR.

J Biol Chem. 2010 May 21;285(21):16248-57. doi: 10.1074/jbc.M109.048785. Epub 2010 Mar 16.

18.

Dissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9.

Yassin ER, Sarma NJ, Abdul-Nabi AM, Dombrowski J, Han Y, Takeda A, Yaseen NR.

PLoS One. 2009 Aug 21;4(8):e6719. doi: 10.1371/journal.pone.0006719.

19.

Glucose-responsive regulators of gene expression in Saccharomyces cerevisiae function at the nuclear periphery via a reverse recruitment mechanism.

Sarma NJ, Haley TM, Barbara KE, Buford TD, Willis KA, Santangelo GM.

Genetics. 2007 Mar;175(3):1127-35. Epub 2007 Jan 21.

20.

Reverse recruitment: the Nup84 nuclear pore subcomplex mediates Rap1/Gcr1/Gcr2 transcriptional activation.

Menon BB, Sarma NJ, Pasula S, Deminoff SJ, Willis KA, Barbara KE, Andrews B, Santangelo GM.

Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5749-54. Epub 2005 Apr 7.

Supplemental Content

Loading ...
Support Center